查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1556865

组织心臟瓣膜的全球市场

Tissue Heart Valves
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球组织心臟瓣膜市场预计将达到 18 亿美元

全球组织心臟瓣膜市场预计 2023 年为 15 亿美元，预计到 2030 年将达到 18 亿美元，2023-2030 年分析期间复合年增长率为 2.4%。支架瓣膜是本报告分析的细分市场之一，预计复合年增长率为 2.6%，到分析期结束时将达到 13 亿美元。在分析期间，无支架瓣膜细分市场的复合年增长率预计为 1.9%。

美国市场预估为4.097亿美元，中国预期复合年增长率为4.9%

预计 2023 年美国组织心臟瓣膜市场规模将达 4.097 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达3.54亿美元，2023-2030年分析期间复合年增长率为4.9%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 0.6% 和 1.8%。在欧洲，德国的复合年增长率预计为 1.2%。

全球组织心臟瓣膜市场－主要趋势与驱动因素总结

组织心臟瓣膜如何改善心血管手术的结果？

组织心臟瓣膜，也称为生物瓣膜，透过提供机械瓣膜的替代品，具有更自然的血流动力学并减少抗凝血治疗的需求，正在彻底改变心血管手术。这些瓣膜通常由动物组织製成，例如猪心瓣膜或牛心包膜，并经过处理以防止排斥并确保耐用性。组织瓣膜对于某些患者族群特别有利，包括老年人，他们无法忍受机械瓣膜所需的终身抗凝血治疗。使用组织瓣膜可以透过提供更安静的操作和不太严格的血液稀释治疗来显着改善生活品质。此外，这些瓣膜的设计和製造方面的进步提高了它们的耐用性和性能，使其适用于更广泛的患者，并因其生理益处和易于植入而越来越受到外科医生的青睐。

哪些技术创新正在增强组织心臟瓣膜的功能？

组织心臟瓣膜的创新着重于提高耐用性、降低併发症风险和提高患者适用性。一项重要的进展是使用新的抗钙化治疗，透过防止钙沉积（生物瓣膜退化的常见原因）来延长组织瓣膜的寿命。此外，透过采用电脑辅助设计和製造等技术，我们製造的瓣膜更接近患者心臟的自然解剖结构，改善贴合性和功能，并减少瓣膜洩漏和瓣膜洩漏故障的风险。也开发了将组织元件和合成材料结合的混合瓣膜，以提供机械瓣膜的耐用性，同时保持组织瓣膜的生理益处。这些技术进步不仅扩大了组织心臟瓣膜对各种患者群体的适用性，而且还提高了心臟瓣膜置换手术的整体安全性和结果。

组织心臟瓣膜如何影响患者的復健和长期健康？

组织心臟瓣膜透过提供更自然的心臟功能并消除终生强化抗凝血治疗的需要，对患者的復健和长期健康产生重大影响。与组织瓣膜瓣膜的患者形成血栓的风险较低，通常生活方式和饮食限制较少。抗凝血剂需求的减少降低了出血併发症的风险，这对于老年人和生活方式因素增加出血风险的患者尤其重要。从长远来看，与组织瓣膜相关的更多生理流体动态也往往会导致更好的心臟功能，有助于改善整体健康和福祉。然而，儘管组织瓣膜的使用寿命不如机械瓣膜，但瓣膜治疗和技术的进步不断延长其使用寿命，使其成为越来越多患者的可行选择。

推动组织心臟瓣膜市场成长的趋势是什么？

全球老化、心臟瓣膜疾病发生率增加以及对微创手术干预的偏好等趋势推动了组织心臟瓣膜市场的成长。随着人口老化，需要瓣膜置换的疾病（例如主动脉瓣狭窄）的盛行率不断增加。组织瓣膜在老年手术中特别有吸引力，因为它们符合患者的自然生理机能并减少抗凝血治疗的需要。此外，使用组织瓣膜的经导管主动脉瓣置换术（TAVR）等微创手术的需求不断增长，正在显着影响市场的成长。这些手术可以加速患者的康復，通常适合那些被认为是进行心臟直视手术的高风险患者。最后，生物瓣膜技术的不断改进，透过延长使用寿命和改善患者治疗效果来增加其吸引力，也是推动组织心臟瓣膜市场扩张的关键因素。

受访企业范例（36家知名企业）

  • Abbott Cardiovascular
  • Arrotek Medical
  • Artivion, Inc
  • Beijing Balance Medical Technology Co.,Ltd.
  • Boston Scientific Corporation
  • Braile Biomedica
  • BridgeMed Solutions
  • Colibri Heart Valve LLC
  • Edwards Lifesciences Corporation
  • JC Medical, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP24235

Global Tissue Heart Valves Market to Reach US$1.8 Billion by 2030

The global market for Tissue Heart Valves estimated at US$1.5 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Stented Valves, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Stentless Valves segment is estimated at 1.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$409.7 Million While China is Forecast to Grow at 4.9% CAGR

The Tissue Heart Valves market in the U.S. is estimated at US$409.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$354.0 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Tissue Heart Valves Market - Key Trends and Drivers Summarized

How Are Tissue Heart Valves Enhancing Cardiac Surgery Outcomes?

Tissue heart valves, also known as bioprosthetic valves, are revolutionizing cardiac surgery by providing alternatives to mechanical valves with more natural hemodynamics and reduced requirements for anticoagulation therapy. These valves are typically made from animal tissues, such as porcine heart valves or bovine pericardium, which are treated to prevent rejection and ensure durability. Tissue valves are particularly advantageous for certain patient groups, including older adults, who may not tolerate the lifelong anticoagulation medication required with mechanical valves. The use of tissue valves can significantly improve quality of life by offering quieter operation and less rigid blood thinning regimes. Moreover, advancements in the design and fabrication of these valves have improved their durability and performance, making them suitable for a wider range of patients and increasingly preferred by surgeons for their physiological benefits and ease of implantation.

What Innovations Are Enhancing the Functionality of Tissue Heart Valves?

Innovations in tissue heart valves are focusing on extending durability, reducing the risk of complications, and enhancing patient compatibility. One significant advancement is the use of novel anticalcification treatments that extend the lifespan of tissue valves by preventing calcium deposits, a common cause of degeneration in bioprosthetic valves. Additionally, technologies such as computer-aided design and manufacturing are being employed to create valves that more closely mimic the natural anatomy of the patient’s heart, improving fit and function while reducing the risk of leakage or valve failure. Hybrid valves that combine tissue elements with synthetic materials are also being developed to offer the durability of mechanical valves while maintaining the physiological advantages of tissue valves. These technological advancements are not only expanding the applicability of tissue heart valves across different patient demographics but also improving the overall safety and outcomes of heart valve replacement surgeries.

How Do Tissue Heart Valves Impact Patient Recovery and Long-Term Health?

Tissue heart valves significantly impact patient recovery and long-term health by providing a more natural heart function and eliminating the need for intense lifelong anticoagulation therapy. Patients with tissue valves typically experience fewer restrictions on their lifestyle and diet compared to those with mechanical valves, as the risk of blood clot formation is lower. This reduction in the need for anticoagulation drugs decreases the risk of bleeding complications, which is particularly important for the elderly or those with lifestyle factors that increase bleeding risks. The more physiological flow dynamics associated with tissue valves also tend to result in better cardiac function over time, contributing to improved overall health and well-being. However, while tissue valves do not last as long as mechanical valves, the advances in valve treatment and technology continue to extend their lifespan, making them a viable option for an increasing number of patients.

What Trends Are Driving Growth in the Tissue Heart Valves Market?

The growth of the tissue heart valves market is driven by trends such as the aging global population, increasing incidences of heart valve diseases, and preferences for less invasive surgical interventions. As the population ages, the prevalence of conditions that require valve replacement, such as aortic stenosis, is rising. Tissue valves are particularly appealing in geriatric surgery due to their compatibility with the patient's natural physiology and reduced requirement for anticoagulation. Additionally, the increasing demand for minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR), which uses tissue valves, is significantly influencing market growth. These procedures allow for quicker patient recovery and are often suitable for patients who are considered high-risk for open-heart surgery. Lastly, continuous improvements in bioprosthetic valve technologies, which enhance their appeal through longer service lives and better patient outcomes, are also key factors driving the expansion of the tissue heart valves market.

Select Competitors (Total 36 Featured) -

  • Abbott Cardiovascular
  • Arrotek Medical
  • Artivion, Inc
  • Beijing Balance Medical Technology Co.,Ltd.
  • Boston Scientific Corporation
  • Braile Biomedica
  • BridgeMed Solutions
  • Colibri Heart Valve LLC
  • Edwards Lifesciences Corporation
  • JC Medical, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tissue Heart Valves - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Preference for Bioprosthetic Over Mechanical Valves Drives Market Growth
    • Rising Global Incidence of Valve Diseases Bolsters Demand for Tissue Heart Valves
    • Minimally Invasive Valve Replacement Techniques Propel Use of Tissue Valves
    • Aging Population Demographics Increase Prevalence of Valve Replacement Surgeries
    • Patient-Specific Customization and 3D Printing Innovations in Valve Manufacturing
    • Global Expansion of Healthcare Infrastructure Improves Access to Valve Replacement Therapy
    • Insurance and Reimbursement Policies Impact Patient Access to Tissue Heart Valves
    • Advancements in Imaging and Diagnostic Techniques Improve Valve Disease Detection
    • Ongoing Research into Anticalcification Treatments to Extend Valve Life
    • Competition from Non-biological Valve Innovations Shapes Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tissue Heart Valves Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stented Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stented Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stented Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Stentless Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Stentless Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Stentless Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • JAPAN
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • CHINA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • EUROPE
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Tissue Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • FRANCE
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • GERMANY
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Tissue Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • INDIA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Tissue Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Tissue Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • AFRICA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030

IV. COMPETITION